NEW DELHI, INDIA -- (Marketwire) -- 01/06/10 -- Crude oil, merger & acquisition news, commodities prices led the US market high on Monday. The Dow gained 1.50%, the Standard & Poor's 500 rose 1.60% andthe NASDAQ jumped 1.73%. This drove us to do research on the following 6 stocks Agnico-Eagle Mines Ltd. (NYSE: AEM), EnCana Corp. (NYSE: ECA), IAMGOLD Corp. (NYSE: IAG), King Pharmaceuticals Inc. (NYSE: KG), Genzyme Corp. (NASDAQ: GENZ) and Novavax Inc. (NASDAQ: NVAX). You can now access these research reports with many others by signing up at Analyst Choice.
To see if our analysts believe you should BUY, SELL or HOLD these six stocks click on the link below
The following are exempts of the above reports:
-- AEM is trading at its support levels of $64. One could see a bounce back from these levels so investors are advised to... -- In addition, ECA's successful hedging program has helped it sustain strong cash flow. To help preserve the value of... -- Combining this approval with the announcement that the IFC has tentatively accepted IAG's offer to purchase their share in the Sadiola Gold Mine creates... -- KG is trading near to its 6 month high. It has given 25% return in the last 6 months. Technical are bullish for the stock so... -- Although the candidate met its primary endpoint, results showed that it was not more effective than Renvela, a product that is marketed by GENZ. -- We believe NVAX's virus-like particle (VLP) vaccine has also a superior safety and yield profile that will allow Novavax...
About Analyst Choice:
Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. While the world economy undergoes enormous pressure and unprecedented actions are been taken to avoid the worst and boost the shrinking global economic growth, our analysts brings you a bird's eye view of how the big players in the different key sectors and industries of the NASDAQ and NYSE, are coping. Sign up now by visiting the following link.
AnalystChoice.com is an independent financial research portal and as such has not received any compensation by any of the above mentioned companies.